Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariko Seishima

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Immunity, Inflammation and Disease|April 3, 2020
α2AP is associated with the development of lupus nephritis through the regulation of plasmin inhibition and inflammatory responsesYosuke Kanno, Mei Miyashita, Mariko Seishima, et al.
Molecular Medicine Reports|September 18, 2020
Decrease in matrix metalloproteinase‑3 activity in systemic sclerosis fibroblasts causes α2‑antiplasmin and extracellular matrix deposition, and contributes to fibrosis developmentHirofumi Niwa, Yosuke Kanno, En Shu, et al.
The Journal of Dermatology|June 10, 2014
A novel TRPS1 mutation in a family with tricho-rhino-phalangeal syndrome type 1Tomomi Fujisawa, Toshiyuki Fukao, Yutaka Shimomura, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|March 12, 2024
Successful treatment with granulocyte and monocyte adsorption apheresis for plaque-type skin lesions in patients with psoriatic arthritisMariko Seishima, Hideki Hachiken, Takuma Furukawa, et al.
The Journal of Investigative Dermatology|January 9, 2016
The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic SclerosisYosuke Kanno, En Shu, Hiroyuki Kanoh, et al.
Dermatology (Basel, Switzerland)|February 16, 2008
Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremiaMariko Seishima, Yoko Mizutani, Yoshinao Shibuya, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 17, 2009
Decreased factor XIII activity in a patient with subcutaneous bleeding after double filtration plasmapheresisMariko Seishima, Yoshinao Shibuya, Genichi Kato, et al.
Journal of Dermatological Science|December 10, 2019
Activation of STING signaling accelerates skin wound healingYuki Mizutani, Ayumu Kanbe, Hiroyasu Ito, et al.
Molecular Medicine Reports|October 16, 2018
Synergistic effects of vemurafenib and fingolimod (FTY720) in vemurafenib‑resistant melanoma cell linesTomoko Takahashi, Naoko Abe, Hiroyuki Kanoh, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 15, 2007
Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosumMariko Seishima, Yoko Mizutani, Yoshinao Shibuya, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Immunity, Inflammation and Disease|April 3, 2020
α2AP is associated with the development of lupus nephritis through the regulation of plasmin inhibition and inflammatory responsesYosuke Kanno, Mei Miyashita, Mariko Seishima, et al.
Molecular Medicine Reports|September 18, 2020
Decrease in matrix metalloproteinase‑3 activity in systemic sclerosis fibroblasts causes α2‑antiplasmin and extracellular matrix deposition, and contributes to fibrosis developmentHirofumi Niwa, Yosuke Kanno, En Shu, et al.
The Journal of Dermatology|June 10, 2014
A novel TRPS1 mutation in a family with tricho-rhino-phalangeal syndrome type 1Tomomi Fujisawa, Toshiyuki Fukao, Yutaka Shimomura, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|March 12, 2024
Successful treatment with granulocyte and monocyte adsorption apheresis for plaque-type skin lesions in patients with psoriatic arthritisMariko Seishima, Hideki Hachiken, Takuma Furukawa, et al.
The Journal of Investigative Dermatology|January 9, 2016
The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic SclerosisYosuke Kanno, En Shu, Hiroyuki Kanoh, et al.
Dermatology (Basel, Switzerland)|February 16, 2008
Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremiaMariko Seishima, Yoko Mizutani, Yoshinao Shibuya, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 17, 2009
Decreased factor XIII activity in a patient with subcutaneous bleeding after double filtration plasmapheresisMariko Seishima, Yoshinao Shibuya, Genichi Kato, et al.
Journal of Dermatological Science|December 10, 2019
Activation of STING signaling accelerates skin wound healingYuki Mizutani, Ayumu Kanbe, Hiroyasu Ito, et al.
Molecular Medicine Reports|October 16, 2018
Synergistic effects of vemurafenib and fingolimod (FTY720) in vemurafenib‑resistant melanoma cell linesTomoko Takahashi, Naoko Abe, Hiroyuki Kanoh, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 15, 2007
Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosumMariko Seishima, Yoko Mizutani, Yoshinao Shibuya, et al.
Pageof 11